🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Universitaire de Nīmes
NCT07256444 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patient reported outcomes (PRO) measure the health status directly reported by the patients, without external interpretation, generally collected using self-questionnaires, including online tools (ePRO). This approach is useful in early detection of signs of relapse, with reduced anxiety, improved quality of life and survival, and reduced readmissions to emergency departments in patients with advanced cancer. In the current context where hospitalization is increasingly short, the transition from hospital to home is a critical moment that poses a significant safety challenge Patient follow-up strategies help patients return home, particularly in surgery, with telephone calls from a nurse the day after or several days after discharge. In oncology, telephone calls from the pharmacist 3 days after discharge from hospital helped to identify undesirable effects of treatments. In general medici

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Adult patient hospitalized in an oncology unit for at least 48 hours. * Patient capable of using a connected device, in possession of a smartphone or tablet, and with an internet connection at home. * Patient discharged from hospital to go home. Exclusion Criteria: * The patient is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * Patient considered to be at the end of life. * Patient unable to read and understand French * Patient discharged from hospitalization to a home care facility * Patient having been hospitalized in a full-time inpatient setting for a scheduled procedure (chemotherapy or interventional procedure) * Pregnant, parturient, or breastfeeding
💊

What it tests

  • OncoCare transition program
📍

Where

1 site
Centre Hospitalier de Nimes
Nîmes, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy